One of the hallmarks of advanced malignancies is continuous cell growth and this almost universally correlates with the reactivation of telomerase. Although there is still much we do not understand about the regulation of telomerase, it remains a very attractive and novel target for cancer therapeutics. Several clinical trials have been initiated, and in this review we highlight some of the most promising approaches and conclude by speculating on the role of telomerase in cancer stem cells.British Journal of Cancer (2008) 98, 677-683. doi:10.1038/sj.bjc.6604209 www.bjcancer.com Published online 29 January 2008.
Targeting telomerase for cancer therapeutics. Publishing Authors By Initials
Targeting telomerase for cancer therapeutics. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: British journal of cancer
VOLUME: 98
Page Numbers: 677-83
Journal Abbreviation: Br. J. Cancer
ISSN: 0007-0920
DAY: 29
MONTH: 01
YEAR: 2008
Targeting telomerase for cancer therapeutics. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 370635
Targeting telomerase for cancer therapeutics. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Targeting telomerase for cancer therapeutics. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Targeting telomerase for cancer therapeutics.
AFFILIATION: 1Department of Cell Biology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9030, USA.
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Br J Cancer
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Targeting telomerase for cancer therapeutics Related Publications